Senna

Senna (Senna alexandrina, also written Cassia senna or Cassia angustifolia) is a small flowering shrub whose dried leaves and pods have been used as a laxative for more than a thousand years. It stands out among the plants on this site for an unusual reason: senna is not a gentle folk remedy with thin evidence behind it. It is a genuine, well-studied stimulant laxative — recognized as safe and effective in the U.S. Food and Drug Administration's over-the-counter (OTC) monograph for laxatives, and sold in familiar drugstore products. When people ask “does an herbal laxative actually work?”, senna is the honest answer of “yes.”

But working well and being safe for everyday use are two different things. Senna is meant for short-term, occasional constipation — not as a daily habit. This page explains what senna is, the active compounds that make it work, how it moves your bowels, the solid evidence for its uses (occasional constipation, opioid-related constipation, and bowel-prep before procedures), sensible dosing, and — most importantly — the safety story: cramping, fluid and potassium loss, the debated question of “dependence,” the harmless brown colon staining called melanosis coli, who should steer clear, and the food-and-lifestyle steps that come first.

Table of Contents

  1. What Senna Is
  2. The Active Compounds: Sennosides
  3. How Senna Works
  4. Evidence and Uses: Constipation
  5. Dosing and Products
  6. The Safety Story: Short-Term Use
  7. Chronic Use and Overuse Concerns
  8. Drug Interactions
  9. Who Should Avoid Senna
  10. First-Line Steps Before a Laxative
  11. The Honest Bottom Line
  12. Research Papers
  13. Connections
  14. Featured Videos

What Senna Is

Senna is a shrub in the legume family that grows in warm, dry regions — historically the Nile valley, the Arabian Peninsula, India, and Somalia. The parts used medicinally are the dried leaflets and the flat seed pods (sometimes called “senna pods”). Pods are generally a little gentler than the leaf. Both are sold as loose tea, tea bags, tablets, and liquid.

What makes senna different from most botanicals covered on this site is its regulatory status and the depth of evidence. In the United States, standardized senna extracts (measured as sennosides) are treated as a legitimate over-the-counter laxative drug, not merely a supplement. You will find it under brand names such as Senokot and ex-lax, in generic “senna” and “sennosides” tablets, and in senna-plus-stool-softener combinations. It is also widely used in hospitals and hospice care. In other words, senna has earned its place in mainstream medicine — which is exactly why it deserves a clear-eyed look at both its benefits and its limits.

The Active Compounds: Sennosides

The laxative power of senna comes from a family of molecules called sennosides — specifically sennosides A and B, which are anthraquinone glycosides (also grouped under the older term “anthranoids”). A glycoside is simply an active molecule with one or more sugar units attached. That attached sugar is the key to how senna works, and to its timing.

When you swallow a sennoside, it passes through the stomach and small intestine largely intact and inactive. Your own digestive enzymes cannot easily unlock it. Only when it reaches the large intestine (colon) do the resident gut bacteria strip off the sugar and convert the sennoside into its active form — a compound called rhein anthrone. This is why senna is described as a “prodrug”: it is delivered as an inert package and switched on by your microbiome exactly where it is needed. It also explains why heavy antibiotic use, which disrupts gut bacteria, can blunt senna's effect in some people.

How Senna Works

Once the active rhein anthrone is released in the colon, it does two useful things at the same time:

Because the sennosides first have to travel the length of your gut and be activated by colonic bacteria, senna does not work instantly. The typical onset is about 6 to 12 hours. That timing is the reason the standard advice is to take it at bedtime — you swallow it in the evening and get a bowel movement the next morning, rather than being caught out during the day.

Evidence and Uses: Constipation

Senna is one of the better-studied laxatives, and the evidence for its core use is strong and consistent. Reviews and clinical trials support three main uses:

Occasional (short-term) constipation

For the common, temporary constipation that comes with travel, a change in diet, dehydration, or certain medications, senna reliably produces a bowel movement and is a reasonable choice when dietary steps are not enough. Systematic reviews of chronic constipation treatments consistently place stimulant laxatives like senna among the agents that improve stool frequency and symptoms.

Opioid-induced constipation

Opioid pain medicines slow the gut dramatically, and constipation is one of their most predictable side effects. Because opioids paralyze normal gut movement, a stimulant laxative that directly prods the colon is well suited to the problem. Senna is a first-line, guideline-supported option here, and randomized trials in cancer and palliative-care patients found senna at least as effective as osmotic laxatives such as lactulose — often at lower cost. In hospice and cancer care, starting senna alongside a new opioid prescription is standard practice specifically to head off constipation before it begins.

Bowel preparation before procedures

Senna is also used, often combined with other agents, to help clear the bowel before a colonoscopy or certain surgeries. This is a supervised, one-time use at higher doses — not something to attempt on your own.

The honest framing: senna's job is to relieve constipation. It is not a detox, a weight-loss aid, or a “cleanse.” Any pounds lost after a dose are water and stool weight, not fat, and using senna for weight control is both ineffective and risky (see the safety sections below).

Dosing and Products

Modern senna products are standardized to sennosides, which is a real advantage over raw leaf tea: you know how much active compound you are getting. A typical adult over-the-counter dose is roughly 15–17.2 mg of sennosides once daily at bedtime (for example, one to two tablets of a common brand containing about 8.6 mg sennosides each). Product labels vary, so follow the specific package directions.

The single most important dosing rule is about duration, not amount: senna is intended for short-term use, generally no more than about one to two weeks without checking in with a clinician. If you still need it after that, the problem is not one that a laxative should be managing alone.

The Safety Story: Short-Term Use

Used occasionally and as directed, senna is generally well tolerated. But because it forcefully stimulates the colon and shifts fluid, it has predictable side effects, and a few important cautions. The most common issues, even with normal use, are:

Stop and seek medical advice if a laxative dose is followed by severe or persistent abdominal pain, rectal bleeding, no bowel movement at all (which could signal a blockage), or signs of dehydration such as dizziness, a racing heart, or muscle weakness. Do not keep escalating the dose to force a result.

Chronic Use and Overuse Concerns

Most of senna's bad reputation comes not from occasional use but from chronic, heavy, unsupervised use — often for months or years, and sometimes for weight control or an eating disorder. Three concerns come up repeatedly, and it is worth being honest about how solid each one actually is.

“Dependence” and the “lazy bowel” debate

The classic teaching is that long-term stimulant-laxative use makes the bowel “lazy” — that the colon becomes reliant on the drug and eventually cannot move on its own, a picture once called cathartic colon. This warning is why regulators and clinicians uniformly advise short-term use.

Here is the honest nuance: the strong version of this claim — that ordinary laxative use permanently damages the colon's nerves and creates true dependence — is debated and not well supported by good evidence. Much of it traces to old, very-high-dose animal studies and to case reports in people who were already severely constipated for other reasons. Expert reviews that specifically examined the myths around constipation concluded that the fear of laxative-induced bowel damage is largely overstated. At the same time, people who overuse stimulant laxatives can end up in a genuine cycle where escalating doses seem to be needed — sometimes because of low potassium (which itself slows the gut) or an underlying, untreated cause. The sensible takeaway is not panic, but restraint: use senna short-term because there is no good reason to lean on it long-term, not because a few days of use will ruin your bowel.

Melanosis coli (harmless brown pigmentation)

Regular use of senna and other anthraquinone laxatives can, over months, deposit a brown-to-black pigment in the lining of the colon — a finding called melanosis coli that a doctor may notice during a colonoscopy. It looks dramatic but is harmless and reversible, typically fading within several months to a year after stopping the laxative. It was once feared to raise colon-cancer risk, but well-designed prospective studies of anthranoid-laxative users found no increased risk of colorectal cancer or precancerous polyps. Melanosis coli is best understood as a visible marker that someone has been using an anthraquinone laxative, not as a disease.

Electrolyte and fluid problems

This is the concern with the most real-world teeth. Chronic senna overuse can cause ongoing potassium loss, dehydration, and disturbed salt balance. Low potassium can make constipation worse (a frustrating loop), cause fatigue and muscle weakness, and become dangerous in people with heart conditions or those taking certain medicines (below). This is the mechanism behind most serious harm from laxative misuse.

Drug Interactions

Senna's interactions flow mainly from two things it does: it can lower potassium, and it speeds up the gut, which can change how other oral medicines are absorbed. Talk to a pharmacist or doctor before combining senna with:

Who Should Avoid Senna

Some people should not reach for senna without medical guidance — and some should not use it at all:

First-Line Steps Before a Laxative

Because senna is a short-term tool, it works best on top of the basics that keep bowels moving on their own. For ordinary constipation, try these first — they address causes rather than forcing an outcome:

Our Natural Constipation Relief page covers these food-and-lifestyle strategies in depth, and our Prunes page looks at the fruit with the best evidence base.

The Honest Bottom Line

Senna is the rare herbal remedy that fully lives up to its reputation: it is an effective, legitimate, inexpensive stimulant laxative with genuine clinical evidence and a place in mainstream medicine, especially for occasional constipation and for the predictable constipation caused by opioid pain medicines. If you need short-term help getting things moving, senna is a sound, well-understood choice.

What it is not is a daily supplement or a long-term solution. Reserve it for occasional use — roughly a week or two at most before checking with a clinician — take it at bedtime, start at the lowest effective dose, and stay well hydrated. The scary stories mostly belong to chronic, heavy misuse; the melanosis-coli staining is harmless, and the “lazy bowel” fear is largely overstated, but the potassium and fluid losses of overuse are real. If you find yourself relying on senna most days, that is the signal to stop, look for the underlying cause, and rebuild regularity with fiber, fluids, movement, and food — ideally with your doctor's help.

Research Papers

  1. Ford AC, Suares NC. Effect of laxatives and pharmacological therapies in chronic idiopathic constipation: systematic review and meta-analysis. Gut. 2011;60(2):209–218. doi:10.1136/gut.2010.227132 — pooled trials confirm stimulant laxatives, including senna, improve stool frequency and constipation symptoms.
  2. Ramkumar D, Rao SSC. Efficacy and safety of traditional medical therapies for chronic constipation: systematic review. Am J Gastroenterol. 2005;100(4):936–971. doi:10.1111/j.1572-0241.2005.40925.x — graded review of laxatives that places senna among effective options.
  3. Agra Y, Sacristán A, González M, et al. Efficacy of senna versus lactulose in terminal cancer patients treated with opioids. J Pain Symptom Manage. 1998;15(1):1–7. doi:10.1016/S0885-3924(97)00276-5 — randomized trial finding senna at least as effective as lactulose for opioid constipation, at lower cost.
  4. Passmore AP, Wilson-Davies K, Stoker C, Scott ME. Chronic constipation in long stay elderly patients: a comparison of lactulose and a senna-fibre combination. BMJ. 1993;307(6907):769–771. doi:10.1136/bmj.307.6907.769 — senna-plus-fibre outperformed lactulose for stool frequency in elderly patients.
  5. Müller-Lissner SA, Kamm MA, Scarpignato C, Wald A. Myths and misconceptions about chronic constipation. Am J Gastroenterol. 2005;100(1):232–242. doi:10.1111/j.1572-0241.2005.40885.x — expert review arguing the “laxatives damage the bowel / cause dependence” belief is largely unsupported.
  6. van Gorkom BAP, de Vries EGE, Karrenbeld A, Kleibeuker JH. Review article: anthranoid laxatives and their potential carcinogenic effects. Aliment Pharmacol Ther. 1999;13(4):443–452. doi:10.1046/j.1365-2036.1999.00468.x — reviews melanosis coli and the (unproven) cancer-risk question for senna-type laxatives.
  7. Nusko G, Schneider B, Schneider I, et al. Anthranoid laxative use is not a risk factor for colorectal neoplasia: results of a prospective case control study. Gut. 2000;46(5):651–655. doi:10.1136/gut.46.5.651 — found no increased colorectal cancer or adenoma risk in anthranoid-laxative users.
  8. Morales MA, Hernández D, Bustamante S, Bachiller I. Is senna laxative use associated to cathartic colon, genotoxicity, or carcinogenicity? J Toxicol. 2009;2009:287247. doi:10.1155/2009/287247 — senna-specific safety review of the dependence and cancer questions.
  9. de Witte P. Metabolism and pharmacokinetics of anthranoids. Pharmacology. 1993;47(Suppl 1):86–97. doi:10.1159/000139847 — explains how inactive sennosides are activated by colonic bacteria to rhein anthrone.
  10. Bharucha AE, Lacy BE. Mechanisms, evaluation, and management of chronic constipation. Gastroenterology. 2020;158(5):1232–1249. doi:10.1053/j.gastro.2019.12.034 — comprehensive review placing senna within stepwise constipation management.
  11. Wald A. Constipation: advances in diagnosis and treatment. JAMA. 2016;315(2):185–191. doi:10.1001/jama.2015.16994 — clinical review covering fiber, osmotic, and stimulant laxatives including senna.
  12. Cirillo C, Capasso R. Constipation and botanical medicines: an overview. Phytother Res. 2015;29(10):1488–1493. doi:10.1002/ptr.5410 — reviews senna and other plant laxatives, their mechanisms, and cautions.

Back to Table of Contents

Connections

Back to Table of Contents